- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04695626
Prospective Randomized Controled Study on the Outcome of Greenhouse Tec in the Arthroscopic Treatment of Small to Medium Rotator Cuff Tear
February 8, 2024 updated by: Yi Lu, Beijing Jishuitan Hospital
Prospective Randomized Controled Study on the Outcome of Greenhouse Tec in the Arthroscopic Treatment of Small and Medium Rotator Cuff Tear
This study is aprospective cohort study on the outcome of a combination of bone marrow stimulation and modified suture bridge in the arthroscopic treatment of small and medium rotator cuff tear.
The patients with small to medium rotator cuff injuries (less than 3cm in diameter) requiring arthroscopic surgery were collected.
The patients were followed up before and 6 weeks, 3 months, 6 months and 12 months after surgery, including pain, functional score, joint range of motion, MRI and CT findings, complications and other quantitative and qualitative indicators.
The self-control and intra group analysis were performed to evaluate the treatment effect; and the correlation analysis was performed on the treatment results To determine the important factors affecting the therapeutic effect.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
72
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Guang Yang, M.M.
- Phone Number: +86 13322475760
- Email: yguang1996@126.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100000
- BeiJing JiShuiTan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
According to the inclusion and exclusion criteria, 40 patients with small to middle rotator cuff injury treated by this technique(Greenhouse tec) in our hospital from September 2020 to December 2021 were included.
Description
Inclusion Criteria:
- Arthroscopy confirmed small to medium rotator cuff injury
- The data of preoperative functional examination were complete
- Unilateral rotator cuff injury
- Clinical follow-up can be completed
Exclusion Criteria:
- Anterior superior rotator cuff injury with simple subscapular injury or combined subscapular injury
- Previous shoulder surgery (incision or arthroscopy)
- Combined with diseases of other parts of the same limb
- Combined with Bankart injury, acromioclavicular joint disease, greater tuberosity fracture, glenoid fracture and so on
- Bilateral onset
- Unable or unwilling to receive clinical follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Greenhouse Group
The patients in this group will be underwent Greenhouse tec to repair tendon tears.
|
According to the anteroposterior diameter of the injury, single or double high braided thread were used to suture the tendon in a modified Mason Allen way without knotting.
Bone marrow stimulation was carried out in the footprint area of rotator cuff.
A 2.0 mm diameter cone was created with a depth of 1 cm and a spacing of 5 mm.
Six to eight holes were made due to the diameter of the tear of rotator cuff until blood and fat droplets exudate.
Then the threads were passed through the locking eyelet of the lateral row anchor.
After tightening the threads, the anchor was screwed in at the distal part of the gteater tuberosity.
With this new technique, the rotator cuff was repaired by one lateral row anchor without medial row knotting.
|
Traditional Single Row Group
The patients in this group will be underwent traditional single row repair to repair tendon tears.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
American Shoulder and Elbow Surgeons'Form,ASES score
Time Frame: 1 year postoperatively
|
A score used to evaluated the shoulder function
|
1 year postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Integrity of the tendon in MRI
Time Frame: 1 year postoperatively
|
MRI was performed to identify the status of the tendon
|
1 year postoperatively
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the condition of bone healing in CT
Time Frame: 1 year postoperatively
|
CT was performed to identify the status of the bone healing
|
1 year postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yi Lu, Sports Medicine Service, Beijing Jishuitan hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2020
Primary Completion (Actual)
March 1, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
January 1, 2021
First Submitted That Met QC Criteria
January 3, 2021
First Posted (Actual)
January 5, 2021
Study Record Updates
Last Update Posted (Actual)
February 12, 2024
Last Update Submitted That Met QC Criteria
February 8, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GY
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Marrow Stimulating
-
Zhongnan HospitalNot yet recruitingGranulocyte Colony-Stimulating FactorChina
-
Ospedale Regionale di LocarnoCompletedErythropoiesis Stimulating Agent PharmacodynamicsSwitzerland
-
Heinrich-Heine University, DuesseldorfChugai Pharma USA; Terumo BCTCompletedHealthy Allogeneic Donors | Granulocyte Colony-stimulating Factor (G-CSF) MobilizedGermany
-
Cellenkos, Inc.Active, not recruitingBone Marrow DiseaseUnited States
-
Ning HuangNot yet recruitingGranulocyte Colony-stimulating Factor | Stem Cell Mobilization
-
UNC Lineberger Comprehensive Cancer CenterRecruitingBone Marrow Transplantation | Bone Marrow DiseaseUnited States
-
Elixirgen Therapeutics, Inc.Not yet recruiting
-
Children's Hospital of PhiladelphiaAvailableLeukemia | Immunodeficiencies | Bone Marrow Failure SyndromeUnited States
-
University of CalgaryUnknownBone Marrow Failure Syndrome
-
St. Jude Children's Research HospitalActive, not recruitingAplastic Anemia | Bone Marrow Failure SyndromeUnited States